Back to Newsroom

Immunexpress and Academic Medical Center to Collaborate on Development of Sepsis-Related Biomarker Panels

SEATTLE, April 19, 2016 — Immunexpress Inc. today announced an exclusive collaboration with the Academic Medical Center (AMC) at the University of Amsterdam to characterize and clinically evaluate sepsis and sepsis-related biomarker signatures of the host response. This four-year collaboration with AMC’s Prof. Dr. Tom van der Poll and his team will leverage the informatics expertise of both groups to further the clinical evaluation of proprietary biomarker signatures, as well as additional RNA, protein and epigenetic biomarkers. The collaboration is designed to advance Immunexpress’s commercialization of a pipeline of host response products tailored for improved management of patients with sepsis and suspected of sepsis.

 

Read more here.